Cambridge Healthtech Institute Course - Scaffolds: Bridging the Gap between 2D and 3D

Aug. 25, 2011 - PRLog -- When: Thursday, November 17 (9:00 AM - 12:00 PM)
Where: Omni Parker House, Boston, MA

Three-dimensional (3D) in vitro models aim to bridge the gap between standard two-dimensional (2D) cell-based assays and the in vivo environment. Scaffolds provide the foundation for this dimensional shift. Well-designed scaffolds provide the necessary local structural, mechanical, and environmental cues to direct functional growth. Additionally, scaffolds help preserve the bioactivities of the biomolecules helping control biomolecule distribution and release. This interactive short course is designed to provide practical solutions for moving from 2D to 3D. Build your scaffold expertise!

Keynote Presentation: Silk Scaffolds
David Kaplan, Ph.D., Professor, Engineering, Tufts University

Polymeric Coatings for Tissue Engineering
Melik Demirel, Ph.D., Associate Professor, Engineering Science and Mechanics, Pennsylvania State University

Engineering the Cellular Microenvironment for Microtissue Development
Derek J. Hansford, Ph.D., Associate Professor, Biomedical Engineering, Ohio State University

A Scaffold-Free Multicellular Three-Dimensional in vitro Model of Osteogenesis
Umut A. Gurkan, Ph.D., Postdoctoral Research Fellow in Medicine, Harvard Medical School; Center for Biomedical Engineering, Brigham and Women’s Hospital, Harvard-MIT Health Sciences & Technology

This course will be held prior to the start of CHI’s sixth annual Predictive Functional Human Tissue Models conference that will take place on November 17-18, 2011.

View more details and register for the short course and/or CHI conference at http://www.healthtech.com/3DTissueModels

To inquire about sponsorship/exhibit opportunities, contact Carol Dinerstein at 781-972-5471, dinerstein@healthtech.com.

Writers and editors are invited to attend.  To request a press pass email tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com